MMDMA (lek)

MMDMA
IUPAC ime
	(2-RS)-6-metoksi-7,8-metilendioksi-propan-2-(N-metilamin)
Klinički podaci
Način primene	Oralno
Pravni status
Pravni status	UK: Klasa A ; US: Unscheduled(but possession or sale may be illegal under the Federal Analogue Act in the U.S., and under similar bills in other countries) ;
Identifikatori
CAS broj	172518-52-4
ATC kod	none
ChemSpider	476196
UNII	GR5ZT8ZV9F
Sinonimi	5-MeO-MDMA;3-metoksi-4,5-metilendioksi-N-metilamfetamin
Hemijski podaci
Formula	C12H17NO3
Molarna masa	223,27 g·mol−1
	SMILES COC1=CC(CC(C)NC)=CC2=C1OCO2; ;

5-Metoksi-3,4-metilendioksimetamfetamin (MMDMA; 5-MeO-MDMA) je dezajnirani lek iz klase substituisanih metilendioksifenetilamina (MDxx).^[2] Malo se zna o njegovim efektima i nije formalno proučavan na životinjama.

Reference[уреди | уреди извор]

^ Bailey K, By A, Legault D, Verner D (1976). „Identification of the N-Methylated Analogs of the Hallucinogenic Amphetamines and Some Isomers”. Journal of the Association of Official Analytical Chemists. 58 (1): 62—69.
^ Clark CR, Deruiter J, Noggle FT (1996). „Analysis of 1-(3-methoxy-4,5-methylenedioxyphenyl)-2-propanamine (MMDA) derivatives synthesized from nutmeg oil and 3-methoxy-4,5-methylenedioxybenzaldehyde”. Journal of Chromatographic Science. 34 (1): 34—42. doi:10.1093/chromsci/34.1.34 .

[1] Bailey K, By A, Legault D, Verner D (1976). „Identification of the N-Methylated Analogs of the Hallucinogenic Amphetamines and Some Isomers”. Journal of the Association of Official Analytical Chemists. 58 (1): 62—69.

[2] Clark CR, Deruiter J, Noggle FT (1996). „Analysis of 1-(3-methoxy-4,5-methylenedioxyphenyl)-2-propanamine (MMDA) derivatives synthesized from nutmeg oil and 3-methoxy-4,5-methylenedioxybenzaldehyde”. Journal of Chromatographic Science. 34 (1): 34—42. doi:10.1093/chromsci/34.1.34 .

[1]

[2]